Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

A recent study reveals that resveratrol, a compound present in red wine, may hold the key to effectively treating depression and anxiety without the need for drugs.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

New diet drugs are making it easier to lose weight. So does that mean we can stop exercising? Health experts say no. There is ...

Kelsey Warren [email protected]  609 218 4053 Investor contact: Lauren Johnson [email protected] ...

Table 1. Teratogenic and Adverse Effects Associated With Antidepressants During Pregnancy ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...